Sunrest Lifescience IPO Date, GMP, Price, Analysis and Review
![Sunrest lifescience ipo date, gmp, price, analysis and review 1 Sunrest lifescience ipo details on gmpipo. Com](https://www.gmpipo.com/wp-content/uploads/Sunrest-Lifescience-IPO-Details-on-gmpipo.com-1.png)
Sunrest Lifescience Limited, Incorporated in 2017, offers a wide range of healthcare and personal care products. The company’s product line includes various pharmaceutical forms such as capsules, tablets, syrups, ointments, gels, mouthwash, solutions, suspensions, dry powders, and toothpaste.
Sunrest Lifescience’s product portfolio covers a diverse range of drugs, including anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-protozoal, anti-histamine, anti-hypertensive medications, cosmetics, anti-parasitic, multivitamins, multimineral supplements, nutraceuticals, and anti-inflammatory drugs.
The company partners with third-party pharmaceutical product manufacturers, including Trilend Pharmaceuticals Private Limited, a Sunrest group company. Sunrest Lifescience collaborates with 43 third-party manufacturers across various states in India, including Gujarat, Punjab, Maharashtra, Haryana, Himachal Pradesh, Uttarakhand, and Madhya Pradesh.
Sunrest Lifescience serves a network of stockists and super stockists, making its products available at chemist shops, dispensaries, hospitals, and other healthcare facilities. With 18 registered trademarks covering 32 products, Sunrest Lifescience is dedicated to providing high-quality healthcare and personal care products to its customers.
Objects of the Issue (Sunrest Lifescience IPO Objectives)
The proceeds from the Fresh Issue will be utilized for the following purposes:
- Meeting working capital requirements.
- General corporate purposes.
- Covering public issue expenses.
Sunrest Lifescience IPO Details
Sunrest Lifescience IPO is a fixed-price offering of ₹10.85 crores. The IPO exclusively consists of a fresh issue of 1,291,200 shares.
IPO Date | November 7, 2023 to November 9, 2023 |
Listing Date | November 20, 2023 |
Face Value | ₹10 per share |
Price | ₹84 per share |
Lot Size | 1600 Shares |
Total Issue Size | 1,291,200 shares (aggregating up to ₹10.85 Cr) |
Fresh Issue | 1,291,200 shares (aggregating up to ₹10.85 Cr) |
Issue Type | Fixed Price Issue IPO |
Listing At | NSE SME |
Share holding pre issue | 3,000,000 |
Share holding post issue | 4,291,200 |
Market Maker portion | 65,600 shares |
DRHP Draft Prospectus: | Click Here |
RHP Draft Prospectus: | Click Here |
Sunrest Lifescience IPO Reservation
Investor Category | Shares Offered |
---|---|
Retail Shares Offered | 50% of the Net issue |
Other Shares Offered | 50% of the Net issue |
Sunrest Lifescience IPO Lot Size
Investors can bid in multiples of 1600 shares. See the table for minimum and maximum investments for both retail and HNI investors.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 1600 | ₹134,400 |
Retail (Max) | 1 | 1600 | ₹134,400 |
HNI (Min) | 2 | 3,200 | ₹268,800 |
Sunrest Lifescience IPO Dates
Sunrest Lifescience IPO opens on November 7, 2023, and closes on November 9, 2023.
IPO Open Date | Tuesday, November 7, 2023 |
IPO Close Date | Thursday, November 9, 2023 |
Basis of Allotment | Wednesday, November 15, 2023 |
Initiation of Refunds | Thursday, November 16, 2023 |
Credit of Shares to Demat | Friday, November 17, 2023 |
Listing Date | Monday, November 20, 2023 |
Cut-off time for UPI mandate confirmation | 5 PM on November 9, 2023 |
Sunrest Lifescience Limited Financial Report
Sunrest Lifescience Limited’s revenue declined by -8.32%, but its profit after tax (PAT) increased by 162.91% between the financial years ending on March 31, 2023, and March 31, 2022.
Period Ended | 30 Jun 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
---|---|---|---|---|
Assets | 1,706.28 | 1,671.37 | 1,301.97 | 948.15 |
Revenue | 563.58 | 2,467.05 | 2,690.99 | 1,694.91 |
Profit After Tax | 75.08 | 204.31 | 77.71 | 16.55 |
Net Worth | 386.60 | 311.52 | 107.20 | 29.49 |
Reserves and Surplus | 86.60 | 11.52 | 106.20 | 28.49 |
Total Borrowing | 347.32 | 214.32 | 323.83 | 231.55 |
Key Performance Indicator of Sunrest Lifescience Ltd
KPI | Values |
---|---|
P/E (x) | 12.33 |
ROE | 53% |
ROCE | 98% |
Debt/Equity | 0.64 |
EPS (Rs) | 6.81 |
RoNW | 65.59% |
Sunrest Lifescience IPO Promoter Holding
The promoters of the company are Mr. Nikhilkumar Y Thakkar, Mr. Amitbhai Shambhulal Thakkar, Mr. Bhagyesh Kiritbhai Parekh and Mr. Bharatkumar V Thakkar.
Share Holding Pre Issue | 100% |
Share Holding Post Issue | 69.91% |
Sunrest Lifescience Limited Contact Details
Sunrest Lifescience Limited
FF-41, Ajay Tenament-6,
Near Canal Near Ritanagar, Bus Stand Vastral Road,
Ahmedabad-382415
Phone: +91-079 – 29918245
Email: info@sunrestlifescience.com
Website: https://sunrestlifescience.com/
Sunrest Lifescience IPO Registrar
Skyline Financial Services Private Ltd
Phone: 02228511022
Email: Virenr@Skylinerta.Com
Website: https://www.skylinerta.com/ipo.php
Sunrest Lifescience IPO FAQs
What is Sunrest Lifescience IPO?
Sunrest Lifescience IPO is a SME IPO offering 1,291,200 equity shares with a face value of ₹10 each, aggregating to ₹10.85 Crores. The IPO is priced at ₹84 per share, and the minimum order quantity is 1600 shares. The IPO subscription period is from November 7, 2023, to November 9, 2023, and it is managed by Skyline Financial Services Private Ltd. The shares are intended to be listed on NSE SME.
How can I apply for Sunrest Lifescience IPO through Zerodha?
To apply for Sunrest Lifescience IPO through Zerodha, you can use UPI as the payment gateway. Access Zerodha Console (back office), navigate to the Portfolio section, and click on the IPOs link. Find the ‘Sunrest Lifescience IPO’ row and click ‘Bid.’ Enter your UPI ID, Quantity, and Price, then submit the IPO application form. Finally, visit your UPI App (net banking or BHIM) to approve the mandate.
When will Sunrest Lifescience IPO open?
The Sunrest Lifescience IPO opens on November 7, 2023, and closes on November 9, 2023.
What is the lot size of Sunrest Lifescience IPO?
The lot size for Sunrest Lifescience IPO is 1600 shares, requiring a minimum investment of ₹134,400.
How can I apply for Sunrest Lifescience IPO?
You can apply for Sunrest Lifescience IPO online using either UPI or ASBA as the payment method. ASBA IPO application is available in your bank’s net banking platform, while UPI IPO application is offered by brokerage firms that do not provide banking services. Further details on applying for IPOs online can be found for platforms like Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank, and SBI Bank.
When will Sunrest Lifescience IPO allotment take place?
The Basis of Allotment for Sunrest Lifescience IPO will be finalized on Wednesday, November 15, 2023, with allotted shares credited to your demat account by Friday, November 17, 2023. You can check the Sunrest Lifescience IPO allotment status.
When is Sunrest Lifescience IPO’s listing date?
The listing date for Sunrest Lifescience IPO is yet to be announced, but the tentative date for the listing is Monday, November 20, 2023.